| C Mark Capistrano, MD | |
|
3201 University Dr E, Suite 250, Bryan, TX 77802-3475 | |
| (979) 731-8558 | |
| (979) 731-8654 |
| Full Name | C Mark Capistrano |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 3201 University Dr E, Bryan, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205905494 | NPI | - | NPPES |
| 8V4920 | Other | TX | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | J8943 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| C Mark Capistrano, MD 3201 University Dr E, Suite 250, Bryan, TX 77802-3475 Ph: (979) 731-8558 | C Mark Capistrano, MD 3201 University Dr E, Suite 250, Bryan, TX 77802-3475 Ph: (979) 731-8558 |
News Archive
"Ten months after the West African country of Cote d'Ivoire started to emerge from a presidential election crisis during which almost all hospitals and clinics had to shut down for a good six months because they had been vandalized, looted and occupied, the new government under President Alassane Ouattara is trying to make public health care a priority," including implementing "a new national health regulation, which came into effect on Mar. 1, that offers free health services to pregnant women, children under five years and people suffering from malaria," Inter Press Service reports.
GTx, Inc. (Nasdaq: GTXI), today announced that following a planned safety review, an independent Data Safety Monitoring Board (DSMB) has recommended that the company continue as planned the pivotal Phase III clinical trial evaluating toremifene 20 mg for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia (PIN), a precancerous lesion of the prostate.
Daily calcium intake among adults appears to vary quite widely around the world in distinct regional patterns, according to a new systematic review of research data ahead of World Osteoporosis Day on Friday, Oct. 20.
Two indicators of liver function, glutamyl transferase (GGT) and albumin (ALB) have been implicated in the pathogenesis of atherosclerosis. It is known that the variation in the plasma level of these liver related proteins is genetically influenced.
› Verified 9 days ago
Christopher Joseph Derbes, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2206 E Villa Maria Rd, Bryan, TX 77802 Phone: 979-776-4600 Fax: 979-774-0877 | |
Mrs. Nalini M Dave, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1201d Briarcrest Dr, Bryan, TX 77802 Phone: 979-776-5600 Fax: 979-776-6280 | |
Brent Morgan Gray, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2206 E Villa Maria Rd, Bryan, TX 77802 Phone: 979-776-4600 Fax: 979-774-0877 | |
Dr. Terry R Jenkins, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2215 E Villa Maria Rd, #110, Bryan, TX 77802 Phone: 979-776-2000 Fax: 979-776-0427 | |
Dr. Rejeesh Vijaya Vasudev, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2110 E Villa Maria Rd, Bryan, TX 77802 Phone: 979-822-5555 | |
Dr. Thomas Mark Weber, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2700 E 29th St, Suite 260, Bryan, TX 77802 Phone: 979-774-0012 Fax: 979-774-4636 | |
Dr. Scott Edward Spencer, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2700 E 29th St, 260, Bryan, TX 77802 Phone: 979-774-0012 Fax: 979-774-4636 |